Announcements
- New Drug Application for Accrufer® in South Korea
- Audited results for the year ended 31 Dec 2023
- Business Update for Q1 2024
- Notice of Results
- Unaudited Full Year Trading Update
- Appointment of new Chief Financial Officer
- Q3 2023 U.S. Commercial Highlights
- PDMR Transaction Notification
- Abstract to be presented at Healthcare Conference
- Chief Financial Officer Transition
More ▼
Key statistics
On Monday, Shield Therapeutics PLC (SHIEF:QBB) closed at 0.022, 62.96% above the 52 week low of 0.0135 set on Apr 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.022 |
---|---|
High | 0.022 |
Low | 0.022 |
Bid | -- |
Offer | -- |
Previous close | 0.022 |
Average volume | 10.00k |
---|---|
Shares outstanding | 782.06m |
Free float | 342.71m |
P/E (TTM) | -- |
Market cap | 14.86m GBP |
EPS (TTM) | -0.0458 GBP |
Data delayed at least 15 minutes, as of Jun 03 2024 17:05 BST.
More ▼